Clinical relevance and antimicrobial susceptibility profile of the unknown human pathogen Corynebacterium aurimucosum
Charles R. Lefèvre(Inserm), Vincent Cattoir(Inserm), Marlène Amara(Institut Pasteur), Stéphane Corvec, Olivier Barraud(Inserm), Romain Pelletier(Centre Hospitalier Universitaire de Rennes), Nicolas Degand(Hôpital Necker-Enfants Malades), Vincent Fihman(Université Paris Cité), Alban Le Monnier(Université Paris-Saclay), Emmanuelle Bille(Délégation Paris 5), Anaïs Potron(Centre Hospitalier Universitaire de Besançon), Éric Farfour(European Foundation for Clinical Nanomedicine)
Cited by 14
Related Papers
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
|Science|2020|382
Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature
|Drug Resistance Updates|2018|283
Listeria rocourtiae sp. nov.
|INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY|2009|189
Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy
|Journal of Infection|2016|167
MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures
|Clinical Microbiology and Infection|2011|151